Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment

Gastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric cancer remains extremely poor despite the use of surgery and adjuvant therapy. Therefore, understanding the mechanism of...

Full description

Bibliographic Details
Main Authors: Xiao-Jing Shi, Yongjun Wei, Boyang Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmolb.2020.00203/full
id doaj-05bae95a57b44f3d9a7787c89fbb8530
record_format Article
spelling doaj-05bae95a57b44f3d9a7787c89fbb85302020-11-25T03:41:46ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2020-08-01710.3389/fmolb.2020.00203553175Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and TreatmentXiao-Jing Shi0Yongjun Wei1Boyang Ji2Boyang Ji3Laboratory Animal Center, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Academy of Medical Science, Zhengzhou University, Zhengzhou, ChinaSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou, ChinaDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, SwedenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, DenmarkGastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric cancer remains extremely poor despite the use of surgery and adjuvant therapy. Therefore, understanding the mechanism of gastric cancer development, and the discovery of novel diagnostic biomarkers and therapeutics are major goals in gastric cancer research. Here, we review recent progress in application of omics technologies in gastric cancer research, with special focus on the utilization of systems biology approaches to integrate multi-omics data. In addition, the association between gastrointestinal microbiota and gastric cancer are discussed, which may offer insights in exploring the novel microbiota-targeted therapeutics. Finally, the application of data-driven systems biology and machine learning approaches could provide a predictive understanding of gastric cancer, and pave the way to the development of novel biomarkers and rational design of cancer therapeutics.https://www.frontiersin.org/article/10.3389/fmolb.2020.00203/fullgastric canceromicssystems biologydata integrationpersonalized medicine
collection DOAJ
language English
format Article
sources DOAJ
author Xiao-Jing Shi
Yongjun Wei
Boyang Ji
Boyang Ji
spellingShingle Xiao-Jing Shi
Yongjun Wei
Boyang Ji
Boyang Ji
Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
Frontiers in Molecular Biosciences
gastric cancer
omics
systems biology
data integration
personalized medicine
author_facet Xiao-Jing Shi
Yongjun Wei
Boyang Ji
Boyang Ji
author_sort Xiao-Jing Shi
title Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
title_short Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
title_full Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
title_fullStr Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
title_full_unstemmed Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment
title_sort systems biology of gastric cancer: perspectives on the omics-based diagnosis and treatment
publisher Frontiers Media S.A.
series Frontiers in Molecular Biosciences
issn 2296-889X
publishDate 2020-08-01
description Gastric cancer is the fifth most diagnosed cancer in the world, affecting more than a million people and causing nearly 783,000 deaths each year. The prognosis of advanced gastric cancer remains extremely poor despite the use of surgery and adjuvant therapy. Therefore, understanding the mechanism of gastric cancer development, and the discovery of novel diagnostic biomarkers and therapeutics are major goals in gastric cancer research. Here, we review recent progress in application of omics technologies in gastric cancer research, with special focus on the utilization of systems biology approaches to integrate multi-omics data. In addition, the association between gastrointestinal microbiota and gastric cancer are discussed, which may offer insights in exploring the novel microbiota-targeted therapeutics. Finally, the application of data-driven systems biology and machine learning approaches could provide a predictive understanding of gastric cancer, and pave the way to the development of novel biomarkers and rational design of cancer therapeutics.
topic gastric cancer
omics
systems biology
data integration
personalized medicine
url https://www.frontiersin.org/article/10.3389/fmolb.2020.00203/full
work_keys_str_mv AT xiaojingshi systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment
AT yongjunwei systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment
AT boyangji systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment
AT boyangji systemsbiologyofgastriccancerperspectivesontheomicsbaseddiagnosisandtreatment
_version_ 1724528377511018496